LLY

1,063.53

+1.68%↑

JNJ

205.43

+1.03%↑

ABBV

237.6

+3.53%↑

UNH

321

+2.95%↑

AZN

91.8

+3.47%↑

LLY

1,063.53

+1.68%↑

JNJ

205.43

+1.03%↑

ABBV

237.6

+3.53%↑

UNH

321

+2.95%↑

AZN

91.8

+3.47%↑

LLY

1,063.53

+1.68%↑

JNJ

205.43

+1.03%↑

ABBV

237.6

+3.53%↑

UNH

321

+2.95%↑

AZN

91.8

+3.47%↑

LLY

1,063.53

+1.68%↑

JNJ

205.43

+1.03%↑

ABBV

237.6

+3.53%↑

UNH

321

+2.95%↑

AZN

91.8

+3.47%↑

LLY

1,063.53

+1.68%↑

JNJ

205.43

+1.03%↑

ABBV

237.6

+3.53%↑

UNH

321

+2.95%↑

AZN

91.8

+3.47%↑

Search

West Pharmaceutical Services Inc

Aperta

SettoreSettore sanitario

269.43 4.66

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

253.09

Massimo

270.91

Metriche Chiave

By Trading Economics

Entrata

8.2M

140M

Vendite

38M

804M

P/E

Media del settore

38.933

106.172

EPS

1.96

Rendimento da dividendi

0.32

Margine di Profitto

17.406

Dipendenti

10,600

EBITDA

19M

217M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+35.54% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.32%

2.31%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-889M

19B

Apertura precedente

264.77

Chiusura precedente

269.43

Notizie sul Sentiment di mercato

By Acuity

50%

50%

182 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

20 nov 2025, 23:07 UTC

Discorsi di Mercato

Evidence Of Broad Australian Economic Upswing Mounts -- Market Talk

20 nov 2025, 22:22 UTC

Discorsi di Mercato

Auckland Airport Has Edge Over Transurban In Infrastructure Stocks -- Market Talk

20 nov 2025, 22:08 UTC

Discorsi di Mercato

Revenues of Texas Battery Projects Drop Sharply -- Market Talk

20 nov 2025, 21:57 UTC

Utili

Walmart Reports Strong Sales Growth, Raises Outlook -- 5th Update

20 nov 2025, 21:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Tech, Media & Telecom Roundup: Market Talk

20 nov 2025, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

20 nov 2025, 21:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Health Care Roundup: Market Talk

20 nov 2025, 21:50 UTC

Discorsi di Mercato
Utili

Financial Services Roundup: Market Talk

20 nov 2025, 21:31 UTC

Utili

Nvidia's Strong Results Show AI Fears Are Premature -- Update

20 nov 2025, 21:23 UTC

Utili
Acquisizioni, Fusioni, Takeovers

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More -- Barrons.com

20 nov 2025, 21:07 UTC

Utili

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

20 nov 2025, 21:06 UTC

Utili

Webull 3Q Rev $156.9M >BULL

20 nov 2025, 21:06 UTC

Utili

Webull 3Q EPS 7c >BULL

20 nov 2025, 21:05 UTC

Utili

Intuit 1Q Sales Jump, CFO Cites AI Demand From Mid-Sized Businesses -- Interview

20 nov 2025, 21:04 UTC

Utili

Mid-Sized Businesses Want to Automate Tasks With AI, Intuit CFO Says >INTU

20 nov 2025, 21:04 UTC

Utili

Intuit's AI Offerings Attracted More Mid-Sized Businesses in 1Q, CFO Says >INTU

20 nov 2025, 21:04 UTC

Utili

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

20 nov 2025, 21:00 UTC

Utili

Intuit Sees 2Q Rev $4.52B-$4.55B >INTU

20 nov 2025, 21:00 UTC

Utili

Intuit Sees FY26 GAAP Operating Income $5.78B to $5.86B

20 nov 2025, 21:00 UTC

Utili

Intuit Sees 2Q Adj EPS $3.63-Adj EPS $3.68 >INTU

20 nov 2025, 21:00 UTC

Utili

Intuit Expects FY26 Global Business Solutions Rev Growth of 15.5% to 16.5%, Excluding Mailchimp

20 nov 2025, 21:00 UTC

Utili

Intuit Expects FY26 Consumer Rev Growth of 8% to 9%

20 nov 2025, 21:00 UTC

Utili

Intuit Expects FY26 Global Business Solutions Rev Growth of 14% to 15%

20 nov 2025, 21:00 UTC

Utili

Intuit Backs FY26 Rev $21B-$21.19B >INTU

20 nov 2025, 21:00 UTC

Utili

Intuit Backs FY26 Adj EPS $22.98-Adj EPS $23.18 >INTU

20 nov 2025, 21:00 UTC

Utili

Intuit 1Q Consumer Rev $894M

20 nov 2025, 21:00 UTC

Utili

Intuit Sees 2Q EPS $1.76-EPS $1.81 >INTU

20 nov 2025, 21:00 UTC

Utili

Intuit Backs FY26 Guidance

20 nov 2025, 21:00 UTC

Utili

Intuit Backs FY26 EPS $15.49-EPS $15.69 >INTU

20 nov 2025, 21:00 UTC

Utili

Intuit 1Q Global Business Solutions Rev $3B

Confronto tra pari

Modifica del prezzo

West Pharmaceutical Services Inc Previsione

Obiettivo di Prezzo

By TipRanks

35.54% in crescita

Previsioni per 12 mesi

Media 349.56 USD  35.54%

Alto 375 USD

Basso 311 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per West Pharmaceutical Services Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

11 ratings

10

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

213.26 / 219.27Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

182 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat